Serrapeptase: What It Is and How It Supports Cardi…

Serrapeptase is a proteolytic enzyme originally isolated from the bacteria Serratia marcescens found in the digestive tract of silkworms. It has been used clinically in Europe and Asia for decades to reduce inflammation, clear fibrin, and support vascular health. Its cardiovascular applications are of particular interest for those managing arterial stiffness, plaque buildup, and chronic inflammation.

How Serrapeptase Works

Serrapeptase breaks down non-living protein tissue — specifically fibrin, dead tissue, and inflammatory proteins — without affecting healthy cells. In the cardiovascular context, this means it can degrade fibrin in arterial plaques, reduce circulating inflammatory markers like C-reactive protein (CRP), and thin mucus that contributes to inflammatory burden.

Its anti-inflammatory mechanism is distinct from NSAIDs: rather than blocking prostaglandin synthesis, serrapeptase digests the bradykinin and cytokines that signal inflammation. This means it can reduce swelling and pain without the gastrointestinal side effects of anti-inflammatory drugs.

Cardiovascular and Arterial Applications

German physician Dr. Hans Nieper was among the first to use serrapeptase for arterial plaque management in the 1980s. He reported case observations of fibrin reduction in arteries of patients with atherosclerosis, though large-scale randomized trials remain limited.

More recent research supports serrapeptase's role in reducing fibrinogen, a clotting protein that is an independent cardiovascular risk factor. Elevated fibrinogen is associated with increased blood viscosity, clot formation, and inflammatory atherosclerosis. By degrading excess fibrinogen, serrapeptase may reduce these risks.

Anti-Inflammatory Benefits

Chronic low-grade inflammation drives arterial plaque progression. Studies on serrapeptase show significant reductions in CRP and IL-6 in inflammatory conditions. These are the same biomarkers that predict cardiovascular events in large epidemiological studies. While direct cardiovascular endpoint trials are lacking, the inflammatory pathway is mechanistically compelling.

Dosage and Timing

Serrapeptase must be enteric-coated to survive stomach acid and reach the small intestine where it is absorbed. Standard doses range from 10 mg (20,000 SPU) to 60 mg (120,000 SPU) per day. For cardiovascular and anti-inflammatory applications, 20–30 mg twice daily on an empty stomach is a common protocol.

Take serrapeptase at least 30 minutes before meals or 2 hours after. Never crush or chew enteric-coated capsules, as stomach acid will inactivate the enzyme.

Combining Serrapeptase with Nattokinase

Many practitioners combine serrapeptase and nattokinase as a systemic enzyme therapy stack. They act through complementary mechanisms — nattokinase targeting fibrin directly, serrapeptase reducing inflammatory proteins and dead tissue. Products combining both at therapeutic doses are available, and the combination is widely used in integrative cardiology.

Use caution if combining with anticoagulants, as the additive effect on blood viscosity and clot formation may increase bleeding tendency.

Safety Profile

Serrapeptase has been used in European clinical practice for over 30 years with a good safety record. The most common adverse effects are mild digestive discomfort when taken with food. There are isolated case reports of pneumonia-like reactions in individuals with certain respiratory conditions, warranting caution in those with chronic lung disease.

FAQ

Q: Is serrapeptase FDA-approved? A: Serrapeptase is not FDA-approved as a drug in the United States. It is sold as a dietary supplement. It is approved as a medical treatment in several European and Asian countries.

Q: Can serrapeptase dissolve existing arterial plaques? A: There is preliminary evidence it may reduce fibrin components of soft plaque. It is unlikely to dissolve calcified, hardened plaque. Do not use it as a substitute for medical management of known atherosclerosis.

Q: How long should I take serrapeptase? A: Many protocols suggest cycling — 3 months on, 1 month off — though this is convention rather than clinical guideline. Discuss long-term use with a healthcare provider.

Q: Can I take serrapeptase with blood pressure medication? A: There are no known pharmacokinetic interactions, but always disclose all supplements to your prescribing physician.

Track your supplements in Optimize.

Serrapeptase: What It Is and How It Supports Cardiovascular Health